FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085210003> ?p ?o ?g. }

• W2085210003 endingPage "51" @default.
• W2085210003 startingPage "42" @default.
• W2085210003 abstract "Abstract Refludan (lepirudin-rDNA for injection) is the first direct thrombin inhibitor approved by the United States FDA for anticoagulation to patients with heparin-induced thrombocytopenia (HIT). It was monitored by ecarin clotting time (ECT) assay in patients with HIT. Case histories and clotting parameters for three patients undergoing off-pump coronary artery revascularization procedure are discussed. The first patient received r-hirudin at a dose of 0.2 mg/kg intravenous (IV) bolus followed by 0.15 mg/kg/hour infusion. The second patient received 0.4 mg/kg IV bolus followed by infusion of 0.15 mg/kg/hour infusion. The third patient with renal failure received 0.2 mg/kg IV bolus followed by an infusion of 0.02 mg/kg/hour. Blood samples were drawn at baseline, 5 minutes post bolus and every 15 minutes during the coronary artery revascularization procedure. ECT was performed immediately on the citrated whole blood samples using the ECT cards in conjunction with the point-of-care, the thrombolytic assessment system (TAS) Analyzer (Pharmanetics, Raleigh, NC). The plasma samples were then analyzed for APTT and liquid ECT assay performed on a kinetic centrifugal analyzer (ACL 300 Plus). The ECT by cards was ideally maintained above 600 seconds during the surgical procedure. Additional boluses of Refludan were given as and when necessary (ECT < 600 sec) in order to maintain adequate anticoagulation. The calculated circulating concentrations of Refludan, following a bolus adminstration, based on the ECT cards, liquid ECT and APTT were 3.20 ± 1.3, 3.51 ± 1.35 and 2.02 ± 1.19 μg/mL, respectively." @default.
• W2085210003 created "2016-06-24" @default.
• W2085210003 creator A5000722087 @default.
• W2085210003 creator A5007859032 @default.
• W2085210003 creator A5034121067 @default.
• W2085210003 creator A5040010155 @default.
• W2085210003 creator A5059935687 @default.
• W2085210003 creator A5064983817 @default.
• W2085210003 creator A5073509080 @default.
• W2085210003 creator A5074304553 @default.
• W2085210003 creator A5083781232 @default.
• W2085210003 creator A5087695849 @default.
• W2085210003 date "2005-01-01" @default.
• W2085210003 modified "2023-09-27" @default.
• W2085210003 title "Successful Use of Recombinant Hirudin and Its Monitoring by Ecarin Clotting Time in Patients with Heparin-Induced Thrombocytopenia Undergoing Off-Pump Coronary Artery Revascularization" @default.
• W2085210003 cites W108425301 @default.
• W2085210003 cites W193975376 @default.
• W2085210003 cites W1968797532 @default.
• W2085210003 cites W1972417290 @default.
• W2085210003 cites W1977452105 @default.
• W2085210003 cites W1992535811 @default.
• W2085210003 cites W2013547341 @default.
• W2085210003 cites W2034782781 @default.
• W2085210003 cites W2036681919 @default.
• W2085210003 cites W2065583607 @default.
• W2085210003 cites W2072759532 @default.
• W2085210003 cites W2085223950 @default.
• W2085210003 cites W2086150454 @default.
• W2085210003 cites W2128025123 @default.
• W2085210003 cites W2333521900 @default.
• W2085210003 cites W2341329900 @default.
• W2085210003 cites W2403638056 @default.
• W2085210003 cites W3151469085 @default.
• W2085210003 cites W4251818240 @default.
• W2085210003 doi "https://doi.org/10.1111/j.0886-0440.2005.200316.x" @default.
• W2085210003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15673409" @default.
• W2085210003 hasPublicationYear "2005" @default.
• W2085210003 type Work @default.
• W2085210003 sameAs 2085210003 @default.
• W2085210003 citedByCount "15" @default.
• W2085210003 countsByYear W20852100032012 @default.
• W2085210003 countsByYear W20852100032020 @default.
• W2085210003 countsByYear W20852100032021 @default.
• W2085210003 crossrefType "journal-article" @default.
• W2085210003 hasAuthorship W2085210003A5000722087 @default.
• W2085210003 hasAuthorship W2085210003A5007859032 @default.
• W2085210003 hasAuthorship W2085210003A5034121067 @default.
• W2085210003 hasAuthorship W2085210003A5040010155 @default.
• W2085210003 hasAuthorship W2085210003A5059935687 @default.
• W2085210003 hasAuthorship W2085210003A5064983817 @default.
• W2085210003 hasAuthorship W2085210003A5073509080 @default.
• W2085210003 hasAuthorship W2085210003A5074304553 @default.
• W2085210003 hasAuthorship W2085210003A5083781232 @default.
• W2085210003 hasAuthorship W2085210003A5087695849 @default.
• W2085210003 hasBestOaLocation W20852100031 @default.
• W2085210003 hasConcept C126322002 @default.
• W2085210003 hasConcept C141071460 @default.
• W2085210003 hasConcept C164705383 @default.
• W2085210003 hasConcept C2776187130 @default.
• W2085210003 hasConcept C2777292125 @default.
• W2085210003 hasConcept C2777557582 @default.
• W2085210003 hasConcept C2777987278 @default.
• W2085210003 hasConcept C2778271848 @default.
• W2085210003 hasConcept C2779464278 @default.
• W2085210003 hasConcept C2780205058 @default.
• W2085210003 hasConcept C42219234 @default.
• W2085210003 hasConcept C43376680 @default.
• W2085210003 hasConcept C500558357 @default.
• W2085210003 hasConcept C57002609 @default.
• W2085210003 hasConcept C71924100 @default.
• W2085210003 hasConcept C77171857 @default.
• W2085210003 hasConcept C89560881 @default.
• W2085210003 hasConceptScore W2085210003C126322002 @default.
• W2085210003 hasConceptScore W2085210003C141071460 @default.
• W2085210003 hasConceptScore W2085210003C164705383 @default.
• W2085210003 hasConceptScore W2085210003C2776187130 @default.
• W2085210003 hasConceptScore W2085210003C2777292125 @default.
• W2085210003 hasConceptScore W2085210003C2777557582 @default.
• W2085210003 hasConceptScore W2085210003C2777987278 @default.
• W2085210003 hasConceptScore W2085210003C2778271848 @default.
• W2085210003 hasConceptScore W2085210003C2779464278 @default.
• W2085210003 hasConceptScore W2085210003C2780205058 @default.
• W2085210003 hasConceptScore W2085210003C42219234 @default.
• W2085210003 hasConceptScore W2085210003C43376680 @default.
• W2085210003 hasConceptScore W2085210003C500558357 @default.
• W2085210003 hasConceptScore W2085210003C57002609 @default.
• W2085210003 hasConceptScore W2085210003C71924100 @default.
• W2085210003 hasConceptScore W2085210003C77171857 @default.
• W2085210003 hasConceptScore W2085210003C89560881 @default.
• W2085210003 hasIssue "1" @default.
• W2085210003 hasLocation W20852100031 @default.
• W2085210003 hasLocation W20852100032 @default.
• W2085210003 hasOpenAccess W2085210003 @default.
• W2085210003 hasPrimaryLocation W20852100031 @default.
• W2085210003 hasRelatedWork W1978439664 @default.
• W2085210003 hasRelatedWork W2012257575 @default.
• W2085210003 hasRelatedWork W2027554730 @default.
• W2085210003 hasRelatedWork W2042158584 @default.

• next